Drugs Health Pharma

UK consortium to build world’s first real-time pandemic surveillance system

The UK, along with a clutch of government and private entities, has set afoot plans to create the world’s first real-time surveillance system.

Read More
Drugs Health Pharma

Birth by C-section may double the chance of measles vaccine failure

HQ Team May 17, 2024: A measles vaccine given to a child born by caesarean section is likely to be 2.6 times completely.

Read More
Climate Health Medical

Warming oceans drive flesh-eating bacteria northward, increasing infections

HQ Team April 15,2024:Adding to the climate change worries is the fear Vibrio vulnificus, commonly known as flesh-eating bacteria, is expanding its territory.

Read More
Drugs Health Pharma

Moderna expects to break even in 2026, says CEO Stéphane Bancel

HQ Team January 5, 2023: Moderna Inc., expects to break even in 2026 as it aims to drive profits by “disciplined investment” and.

Read More
Health Medical Pharma

Amidst conflict, Gaza battles dual threat of disease and hunger

HQ Team January 1, 2024: As the conflict in Gaza rages on, a dual crisis emerges, with infectious diseases and hunger posing severe.

Read More
Drugs Health Pharma

Opinion: Steps for prevention, spread, and monitoring pneumonia

By K. Leelamoni November 5, 2023: Outbreaks of pneumonia affecting children in parts of northern China, the US,  the Netherlands, and Denmark are higher than.

Read More
Drugs Health Medical Pharma

Signs of post-COVID-19 global health system recovery surface

HQ Team May 3, 2023: First major signs of health system recovery, after three years of the COVID-19 pandemic, were visible at the.

Read More
Drugs Medical Pharma

Merck’s pill fails to prevent COVID-19 infection among households

Merck's COVID-19 pill does not stop the risk of prevention of the virus spreading to others in a household, the company stated.

Read More
Drugs Health Medical Pharma

Novavax to supply 1.5m COVID-19 vaccine doses to US

Novavax, a US biotechnology company, announced it would deliver 1.5 million doses of its COVID-19 adjuvanted vaccine to the government.

Read More
Drugs Pharma

BioNTech to invest $43 million in new mRNA facility

BioNTech SE, an immunotherapy company, will invest $43 million in a new facility in Germany to make a vital ingredient for its mRNA.

Read More